October 8, 2013
65th Edition – October 8, 2013
You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing this…
October 7, 2013
Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences
Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD), has successfully developed…
October 7, 2013
Glycomimetics Files Registration Statement for Proposed Initial Public Offering – GlycoMimetics
GlycoMimetics, Inc. announced today that it has filed a registration statement on Form S-1 with…
October 7, 2013
High Blood Sugar Linked with Cancer – TeleManagement
Even people without diabetes could be at higher risk of dying from disease High blood…
October 7, 2013
BioMarker Strategies Appoints Jerry Parrott President and CEO – HispanicBusiness.com
BioMarker Strategies announced the appointment of Jerry Parrott as President, Chief Executive Officer and Director,…
October 7, 2013
Fyodor Awarded SBIR Phase 2 Grant
Fyodor, a Baltimore-based biotechnology company, announced today that the US National Science Foundation (NSF) has…
October 7, 2013
Epigenomics AG: Epigenomics signs joint commercialization agreement for Epi proColon® in North America with Polymedco
Berlin, Germany, and U.S.A. - Epigenomics AG (Frankfurt Prime Standard: ECX, OTC: EPGNY), the German-American…
October 7, 2013
New Enterprise Associates joins $10M round for drug accelerator – Washington Business Journal
Chevy Chase-based New Enterprise Associates has joined in a $10 million financing for Cydan LLC,…